Category: E16 - Other disorders of pancreatic internal secretion

 Chapter Notes

 E16

Other disorders of pancreatic internal secretion

 E16.0

Drug-induced hypoglycemia without coma

diabetes with hypoglycemia without coma (E09.649)

Use additional code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

 E16.1

Other hypoglycemia

Functional hyperinsulinism

Functional nonhyperinsulinemic hypoglycemia

Hyperinsulinism NOS

Hyperplasia of pancreatic islet beta cells NOS

diabetes with hypoglycemia (E08.649, E10.649, E11.649, E13.649)

hypoglycemia in infant of diabetic mother (P70.1)

neonatal hypoglycemia (P70.4)

 E16.2

Hypoglycemia, unspecified

diabetes with hypoglycemia (E08.649, E10.649, E11.649, E13.649)

 E16.3

Increased secretion of glucagon

Hyperplasia of pancreatic endocrine cells with glucagon excess

 E16.4

Increased secretion of gastrin

Hypergastrinemia

Hyperplasia of pancreatic endocrine cells with gastrin excess

Zollinger-Ellison syndrome

 E16.8

Other specified disorders of pancreatic internal secretion

Increased secretion from endocrine pancreas of growth hormone-releasing hormone

Increased secretion from endocrine pancreas of pancreatic polypeptide

Increased secretion from endocrine pancreas of somatostatin

Increased secretion from endocrine pancreas of vasoactive-intestinal polypeptide

 E16.9

Disorder of pancreatic internal secretion, unspecified

Islet-cell hyperplasia NOS

Pancreatic endocrine cell hyperplasia NOS